Posted: May 8th, 2017
Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Supreme Court of the Netherlands, 14 April 2017, Case No. ECLI:NL:HR:2017:692 Preliminary injunction proceedings. Patent for second medical indication. Swiss-type claim. Novartis owns EP 1 296 689 with a Swiss type claim for use of zoledronic acid in the preparation of a medicament for the treatment of […]
READ MOREPosted: April 11th, 2017
Sun Pharmaceutical Industries (Europe) B.V. v. Novartis AG, Novartis Pharma GmbH, District Court The Hague, 5 April 2017, Case No. ECLI:NL:RBDHA:2017:3430 The 5 April decision is the final decision in first instance. A previous interim decision was rendered on 25 November 2015 and was published on this blog here. Sun sued Novartis in main proceedings claiming […]
READ MOREPosted: March 27th, 2017
IPCom v HTC, UK Court of Appeal, 28 February 2017, neutral citation number [2017] EWCA Civ 90 The Court of Appeal has handed down the latest decision in the long running litigation between IPCom and HTC. IPCom had appealed the High Court’s decision that HTC’s smartphones did not infringe IPCom’s European Patent (UK) 1 841 […]
READ MOREPosted: March 14th, 2017
Budapest Court Grants Preliminary Injunction Based on Direct Threat of Patent Infringement Preventing Pharmaceutical Product Launch The Metropolitan Court, Budapest has recently issued an order granting preliminary injunction against a Hungarian pharmaceutical distributor. The specialty of the case is that the allegedly infringing pharmaceutical product was not yet launched and it is the first time […]
READ MOREPosted: February 27th, 2017
AP Racing Limited v Alcon Components Limited, Intellectual Property Enterprise Court (HHJ Hacon), 15 February 2017, Neutral Citation Number [2017] EWHC 248 (IPEC) This was the second occasion on which AP Racing and Alcon had come to trial in a dispute over brake callipers for use on racing cars. The first trial, heard in December […]
READ MOREPosted: January 20th, 2017
Pregabalin PI in France: a decision dealing with skinny label, second medical use claims and contributory infringement A new pregabalin decision has been rendered on December 2, 2016 in France, in a PI litigation initiated by Warner-Lambert (hereafter: the patentee) and licensees Pfizer against 9 groups of generic companies (hereafter: the defendants). All defendants are […]
READ MOREPosted: January 11th, 2017
DSM IP Assets B.V. v. Novozymes A/S, PI Judge of the District Court of The Hague, The Netherlands, 6 January 2017, Case No. ECLI:NL:RBDHA:2017:110 DSM holps a patent entitled ‘Enzyme preparation yielding a clean taste’. During Opposition, the patent was limited to milk sterilised at ultra high temperatures (‘UHT milk’). An appeal at the TBA […]
READ MOREPosted: January 11th, 2017
Rasco D.O.O and Rondaan Transportservice B.V. v. AEBI Schmidt Nederland B.V., District Court The Hague, The Netherlands, 4 January 2017. Case No. ECLI:NL:RBDHA:2017:4 This matter relates to gritters, more specifically lorries with a detachably mounted device. Aebi Schmidt holds a European patent (the “Patent”). After the District Court had ruled against Aebi Schmidt in preliminary injunction […]
READ MOREPosted: January 6th, 2017
Warner-Lambert Company LLC v Sandoz GmbH, UK, High Court (Chancery Division), Mr Justice Arnold, 21 December 2016 These proceedings concerned an application by Sandoz to vary an interim injunction restraining Sandoz from supplying or offering to supply full label generic pregablin granted by Mr Justice Arnold the previous month (“the 17 November Order”). Patent protection […]
READ MORE
EMAIL US
